BioCryst Pharmaceuticals, Inc. (BCRX) SEC filings
BCRX SEC filings moved a median of -0.74% by the close. BCRX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the BCRX overview →
79 measured BCRX SEC filing events.
Where these BCRX SEC filings landedvs 79 measured BCRX SEC filing reactions
| Middle 50% of BCRX SEC filing reactions | -3.11% to +2.54% |
|---|---|
| Median reaction (to close) | -0.74% |
| Measured reactions | 79 |
Point-in-time · zero look-ahead
Half of the 79 BCRX SEC filing events with a measured close landed between -3.11% and +2.54%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q BIOCRYST PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +2.88% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Aug 05 | SEC filing · Form 8-K | +1.22% | -3.92% | |
| Form S-8 BIOCRYST PHARMACEUTICALS | SEC filing · Form S-8 | +0.00% | +2.88% | |
| Form 8-K/A BIOCRYST PHARMACEUTICALS For: Jun 25 | SEC filing · Form 8-K | +0.45% | +2.27% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jun 25 | SEC filing · Form 8-K | +0.35% | -3.44% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jun 11 | SEC filing · Form 8-K | +0.80% | +3.42% | |
| Form 10-Q BIOCRYST PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -1.36% | +1.14% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: May 06 | SEC filing · Form 8-K | -6.72% | +3.88% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: May 04 | SEC filing · Form 8-K | +0.76% | +0.44% | |
| Form ARS BIOCRYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | -0.23% | +2.52% | |
| Form DEF 14A BIOCRYST PHARMACEUTICALS For: Jun 11 | SEC filing · Form DEF | -0.23% | +2.52% | |
| Form DEFA14A BIOCRYST PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.23% | +2.52% | |
| Form 10-K BIOCRYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +4.78% | +10.06% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Feb 26 | SEC filing · Form 8-K | -4.91% | -3.07% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jan 23 | SEC filing · Form 8-K | +1.92% | +1.03% | |
| Form 8-K/A BIOCRYST PHARMACEUTICALS For: Oct 14 | SEC filing · Form 8-K | +1.92% | +1.03% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jan 12 | SEC filing · Form 8-K | -4.28% | -5.33% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jan 09 | SEC filing · Form 8-K | +1.56% | -3.27% | |
| Form EFFECT BIOCRYST PHARMACEUTICALS | SEC filing · Form EFFECT | +0.84% | +2.35% | |
| Form S-4/A BIOCRYST PHARMACEUTICALS | SEC filing · Form S-4 | +2.94% | -0.78% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Dec 12 | SEC filing · Form 8-K | -3.21% | -3.20% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Dec 09 | SEC filing · Form 8-K | +1.04% | -1.30% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Dec 03 | SEC filing · Form 8-K | +0.42% | +9.64% | |
| Form S-4 BIOCRYST PHARMACEUTICALS | SEC filing · Form S-4 | +1.14% | -0.85% | |
| Form 10-Q BIOCRYST PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +2.62% | +4.52% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Nov 03 | SEC filing · Form 8-K | +0.70% | -3.92% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Oct 14 | SEC filing · Form 8-K | +0.83% | -3.17% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Oct 01 | SEC filing · Form 8-K | -0.67% | -0.94% | |
| Form S-8 BIOCRYST PHARMACEUTICALS | SEC filing · Form S-8 | +0.71% | +1.55% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Aug 11 | SEC filing · Form 8-K | -0.30% | -0.24% | |
| Form 10-Q BIOCRYST PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -0.12% | +2.75% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Aug 04 | SEC filing · Form 8-K | -8.86% | -4.49% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jul 25 | SEC filing · Form 8-K | +0.06% | -1.33% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jul 07 | SEC filing · Form 8-K | +0.34% | -1.68% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jun 27 | SEC filing · Form 8-K | -0.63% | -5.38% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jun 27 | SEC filing · Form 8-K | -2.70% | -6.40% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jun 23 | SEC filing · Form 8-K | -1.20% | -2.01% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jun 11 | SEC filing · Form 8-K | -1.18% | -1.87% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: May 31 | SEC filing · Form 8-K | +0.53% | -1.69% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: May 14 | SEC filing · Form 8-K | -0.64% | -3.15% | |
| Form 10-Q BIOCRYST PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.53% | -2.80% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: May 05 | SEC filing · Form 8-K | +2.00% | +13.01% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Apr 30 | SEC filing · Form 8-K | -1.47% | -1.58% | |
| Form ARS BIOCRYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | +0.37% | +2.57% | |
| Form DEF 14A BIOCRYST PHARMACEUTICALS For: Jun 12 | SEC filing · Form DEF | +0.37% | +2.57% | |
| Form DEFA14A BIOCRYST PHARMACEUTICALS | SEC filing · Form DEFA14A | +0.37% | +2.57% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Apr 06 | SEC filing · Form 8-K | +1.90% | +7.74% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Mar 10 | SEC filing · Form 8-K | +0.07% | +2.17% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Feb 28 | SEC filing · Form 8-K | -2.20% | +4.40% | |
| Form 10-K BIOCRYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -1.26% | +0.48% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Feb 24 | SEC filing · Form 8-K | -7.85% | -7.06% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jan 13 | SEC filing · Form 8-K | -1.42% | +2.06% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jan 10 | SEC filing · Form 8-K | -4.25% | -9.66% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jan 08 | SEC filing · Form 8-K | +0.12% | -0.74% | |
| Form 10-Q BIOCRYST PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +1.39% | +7.51% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Nov 04 | SEC filing · Form 8-K | -3.73% | -5.41% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Oct 02 | SEC filing · Form 8-K | -0.27% | +0.82% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Sep 30 | SEC filing · Form 8-K | -0.53% | +0.40% | |
| Form 10-Q BIOCRYST PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -1.00% | -7.00% | |
| Form S-8 BIOCRYST PHARMACEUTICALS | SEC filing · Form S-8 | -1.00% | -7.00% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Aug 05 | SEC filing · Form 8-K | +8.21% | +15.72% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jun 12 | SEC filing · Form 8-K | -0.24% | +0.65% | |
| Form 10-Q BIOCRYST PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -0.48% | -1.54% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: May 06 | SEC filing · Form 8-K | +0.80% | +5.40% | |
| Form ARS BIOCRYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | -2.14% | -1.19% | |
| Form DEF 14A BIOCRYST PHARMACEUTICALS For: Jun 12 | SEC filing · Form DEF | -2.14% | -1.19% | |
| Form DEFA14A BIOCRYST PHARMACEUTICALS | SEC filing · Form DEFA14A | -2.14% | -1.19% | |
| Form 10-K BIOCRYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +1.56% | -1.04% | |
| Form S-3ASR BIOCRYST PHARMACEUTICALS | SEC filing · Form S-3ASR | +1.56% | -1.04% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Feb 26 | SEC filing · Form 8-K | +2.10% | +1.58% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jan 16 | SEC filing · Form 8-K | -1.83% | -1.39% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Jan 05 | SEC filing · Form 8-K | +3.02% | +21.43% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Nov 28 | SEC filing · Form 8-K | -2.02% | +3.71% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Nov 30 | SEC filing · Form 8-K | +3.26% | +6.52% | |
| Form 10-Q BIOCRYST PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -1.54% | -8.91% | |
| Form S-8 BIOCRYST PHARMACEUTICALS | SEC filing · Form S-8 | -1.54% | -8.91% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Nov 03 | SEC filing · Form 8-K | -1.18% | -5.11% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Nov 02 | SEC filing · Form 8-K | -6.59% | -4.73% | |
| Form 8-K BIOCRYST PHARMACEUTICALS For: Oct 26 | SEC filing · Form 8-K | +0.00% | -0.73% |
Keep exploring
More BCRX: earnings → · analyst actions → · BCRX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CORIUM INTL (CORI) | 380 | 0.00% | 46% |
| PROTEON THERAPEUTICS (PRTO) | 380 | 0.00% | 39% |
| Constellation Pharmaceuticals, Inc (CNST) | 379 | 0.00% | 44% |
| CONTRAVIR PHARMACEUTICALS INC (CTRV) | 379 | -0.51% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.